Direct Alteration of a Specific Inhibitory Circuit of the Hippocampus by Antidepressants

Overview

Journal J Neurosci

Specialty Neurology

Date 2012 Nov 24

PMID 23175817

Citations 28

Authors

Pablo Mendez

Antonio Pazienti

Gabor Szabo

Alberto Bacci

Affiliations

Soon will be listed here.

Abstract

Correct brain functioning relies on the precise activity of a myriad of synapses assembling neurons in complex networks. In the hippocampus, highly diverse inhibitory circuits differently govern several physiologically relevant network activities. Particularly, perisomatic inhibition provided by specific interneurons was proposed to control emotional states, and could therefore be affected by mood disorders and their therapy. We found that both chronic and acute administration of two major antidepressants, imipramine and fluoxetine, strongly and directly altered GABA-mediated (GABAergic) hippocampal neurotransmission in mice and rats, independently of their effects on amine reuptake systems. These drugs affected GABA release from synapses formed by fast-spiking cells, but not interneurons expressing cannabinoid receptor type 1, resulting in the disruption of γ oscillations. This differential effect, shared by two types of antidepressants, suggests a new mechanism of action of these medications, and a possible role of perisomatic inhibition in depressive disorders.

Citing Articles

Sex-specific effects of subchronic NMDA receptor antagonist MK-801 treatment on hippocampal gamma oscillations.

Neuhausel T, Gerevich Z Front Neurosci. 2024; 18:1425323.

PMID: 39170673 PMC: 11335629. DOI: 10.3389/fnins.2024.1425323.

Transcranial alternating current stimulation for the treatment of major depressive disorder: from basic mechanisms toward clinical applications.

Pan R, Ye S, Zhong Y, Chen Q, Cai Y Front Hum Neurosci. 2023; 17:1197393.

PMID: 37731669 PMC: 10507344. DOI: 10.3389/fnhum.2023.1197393.

Acute electroencephalography responses during incremental exercise in those with mental illness.

Robertson C, Skein M, Wingfield G, Hunter J, Miller T, Hartmann T Front Psychiatry. 2023; 13:1049700.

PMID: 36713924 PMC: 9878313. DOI: 10.3389/fpsyt.2022.1049700.

Plasticity of synapses and reward circuit function in the genesis and treatment of depression.

Thompson S Neuropsychopharmacology. 2022; 48(1):90-103.

PMID: 36057649 PMC: 9700729. DOI: 10.1038/s41386-022-01422-1.

ATM rules neurodevelopment and glutamatergic transmission in the hippocampus but not in the cortex.

Focchi E, Cambria C, Pizzamiglio L, Murru L, Pelucchi S, DAndrea L Cell Death Dis. 2022; 13(7):616.

PMID: 35842432 PMC: 9288428. DOI: 10.1038/s41419-022-05038-7.

References

Seamans J, Gorelova N, Durstewitz D, Yang C . Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons. J Neurosci. 2001; 21(10):3628-38. PMC: 6762481. View

Kobayashi K, Ikeda Y, Haneda E, Suzuki H . Chronic fluoxetine bidirectionally modulates potentiating effects of serotonin on the hippocampal mossy fiber synaptic transmission. J Neurosci. 2008; 28(24):6272-80. PMC: 6670533. DOI: 10.1523/JNEUROSCI.1656-08.2008. View

Glickfeld L, Atallah B, Scanziani M . Complementary modulation of somatic inhibition by opioids and cannabinoids. J Neurosci. 2008; 28(8):1824-32. PMC: 3505026. DOI: 10.1523/JNEUROSCI.4700-07.2008. View

Buzsaki G, Draguhn A . Neuronal oscillations in cortical networks. Science. 2004; 304(5679):1926-9. DOI: 10.1126/science.1099745. View

Robinson R, Drafts B, Fisher J . Fluoxetine increases GABA(A) receptor activity through a novel modulatory site. J Pharmacol Exp Ther. 2003; 304(3):978-84. DOI: 10.1124/jpet.102.044834. View

Benes F, Berretta S . GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology. 2001; 25(1):1-27. DOI: 10.1016/S0893-133X(01)00225-1. View

Sanacora G, Mason G, Rothman D, Krystal J . Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry. 2002; 159(4):663-5. DOI: 10.1176/appi.ajp.159.4.663. View

Mohler H . The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology. 2011; 62(1):42-53. DOI: 10.1016/j.neuropharm.2011.08.040. View

Atallah B, Scanziani M . Instantaneous modulation of gamma oscillation frequency by balancing excitation with inhibition. Neuron. 2009; 62(4):566-77. PMC: 2702525. DOI: 10.1016/j.neuron.2009.04.027. View

10.

Maguire J, Mody I . GABA(A)R plasticity during pregnancy: relevance to postpartum depression. Neuron. 2008; 59(2):207-13. PMC: 2875248. DOI: 10.1016/j.neuron.2008.06.019. View

11.

Galarreta M, Erdelyi F, Szabo G, Hestrin S . Cannabinoid sensitivity and synaptic properties of 2 GABAergic networks in the neocortex. Cereb Cortex. 2008; 18(10):2296-305. PMC: 2536700. DOI: 10.1093/cercor/bhm253. View

12.

Glickfeld L, Scanziani M . Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci. 2006; 9(6):807-15. PMC: 3509385. DOI: 10.1038/nn1688. View

13.

Smith K, Rudolph U . Anxiety and depression: mouse genetics and pharmacological approaches to the role of GABA(A) receptor subtypes. Neuropharmacology. 2011; 62(1):54-62. PMC: 3340889. DOI: 10.1016/j.neuropharm.2011.07.026. View

14.

Hajos N, Palhalmi J, Mann E, Nemeth B, Paulsen O, Freund T . Spike timing of distinct types of GABAergic interneuron during hippocampal gamma oscillations in vitro. J Neurosci. 2004; 24(41):9127-37. PMC: 6730063. DOI: 10.1523/JNEUROSCI.2113-04.2004. View

15.

Zhang L, Rasenick M . Chronic treatment with escitalopram but not R-citalopram translocates Galpha(s) from lipid raft domains and potentiates adenylyl cyclase: a 5-hydroxytryptamine transporter-independent action of this antidepressant compound. J Pharmacol Exp Ther. 2009; 332(3):977-84. PMC: 2835448. DOI: 10.1124/jpet.109.162644. View

16.

Wang X . Neurophysiological and computational principles of cortical rhythms in cognition. Physiol Rev. 2010; 90(3):1195-268. PMC: 2923921. DOI: 10.1152/physrev.00035.2008. View

17.

Daw M, Tricoire L, Erdelyi F, Szabo G, McBain C . Asynchronous transmitter release from cholecystokinin-containing inhibitory interneurons is widespread and target-cell independent. J Neurosci. 2009; 29(36):11112-22. PMC: 2762613. DOI: 10.1523/JNEUROSCI.5760-08.2009. View

18.

Lopez-Munoz F, Alamo C . Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009; 15(14):1563-86. DOI: 10.2174/138161209788168001. View

19.

Lee P, Chen Y, Hsieh J, Su T, Chen L . Distinct neuronal oscillatory responses between patients with bipolar and unipolar disorders: a magnetoencephalographic study. J Affect Disord. 2009; 123(1-3):270-5. DOI: 10.1016/j.jad.2009.08.020. View

20.

Ye Z, Zhou K, Xu T, Zhou J . Fluoxetine potentiates GABAergic IPSCs in rat hippocampal neurons. Neurosci Lett. 2008; 442(1):24-9. DOI: 10.1016/j.neulet.2008.06.072. View